Knight Therapeutics | GUD - DEBITO





DEBITO Cambiamento Data
Acasti Pharma USD 0 0 2024-09
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Avita Medical AUD 46.05M 1.46M 2025-12
Canopy Growth CAD 278.71M 19.38M 2026-03
Cronos Group USD 1.31M 198K 2026-03
Dianthus Therapeutics USD 1.36M 79K 2026-03
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
IQVIA Holdings USD 16.24B 408M 2026-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Moderna USD 1.3B 7M 2026-03
Omeros USD 442.16M 199K 2023-09
Organigram Holdings CAD 8.2M 554K 2026-03
Organon & Co USD 8.55B 16M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Tectonic Therapeutic USD 876K 115K 2024-12
Tilray USD 640.95M 35.17M 2022-06
Viatris USD 13.35B 993.3M 2026-06
Xeris Pharmaceuticals USD 258.55M 899K 2026-03